- Home
- ABM vs BCRX Comparison
ABM vs BCRX Comparison
Compare ABM & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABM | BCRX |
|---|---|---|
| Founded | 1909 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.3B |
| IPO Year | 1994 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ABM | BCRX |
|---|---|---|
| Price | $41.03 | $8.86 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 11 |
| Target Price | ★ $47.80 | $20.82 |
| AVG Volume (30 Days) | 340.3K | ★ 3.7M |
| Earning Date | 06-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.92% | N/A |
| EPS Growth | 102.34 | ★ 381.40 |
| EPS | ★ 0.64 | N/A |
| Revenue | ★ $8,745,900,000.00 | $25,186,000.00 |
| Revenue This Year | $5.97 | N/A |
| Revenue Next Year | $3.45 | $12.55 |
| P/E Ratio | $63.63 | ★ $7.28 |
| Revenue Growth | ★ 4.62 | N/A |
| 52 Week Low | $36.96 | $6.00 |
| 52 Week High | $52.94 | $11.31 |
Technical Indicators
Market Signals| Indicator | ABM | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 57.99 | 45.02 |
| Support Level | $39.75 | $8.73 |
| Resistance Level | $46.34 | $9.14 |
| Average True Range (ATR) | 0.82 | 0.44 |
| MACD | 0.12 | -0.04 |
| Stochastic Oscillator | 80.37 | 64.26 |
Price Performance
Historical ComparisonAbout ABM ABM Industries Incorporated
ABM Industries Inc is a provider of integrated facility solutions. It offers its solutions through five segments: Business and Industry, Manufacturing and Distribution, Education, Aviation and Technical solutions. The company derives the majority of its revenue from the business and industry segment, which encompasses janitorial, facilities engineering, and parking services for commercial real estate properties and sports and entertainment venues, hospitals, as well as vehicle maintenance and other services to rental car providers. The company mainly operates in the United States of America.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.